Discrete proteolysis of neuronal calcium sensor-1 (NCS-1) by μ-calpain disrupts calcium binding

Cell Calcium

Volumn 46, Issue 4, 2009, Pages 257-262

  Blachford, Courtney ^a   Ćelić, Andjelka ^a   Petri, Edward T ^a   Ehrlich, Barbara E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain; Cancer; EF hand; Isothermal titration calorimetry; NCS 1; Paclitaxel; Peripheral neuropathy; Taxol

Indexed keywords

CALCIUM ION; CALPAIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; NEURONAL CALCIUM SENSOR; PACLITAXEL;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BREAST CANCER; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER PATIENT; CELL TYPE; CONTROLLED STUDY; IN VITRO STUDY; ISOTHERMAL TITRATION CALORIMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS;

EID: 70349829242     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.08.002     Document Type: Article

References (21)

1. Bourne Y., et al. Immunocytochemical localization and crystal structure of human frequenin (neuronal calcium sensor 1). J. Biol. Chem. 276 15 (2001) 11949-11955
2. 2+-induced conformational changes, and equilibrium unfolding transitions. J. Mol. Biol. 376 4 (2008) 1100-1115
3. Schlecker C., et al. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J. Clin. Invest. 116 6 (2006) 1668-1674
4. Boehmerle W., et al. Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 103 48 (2006) 18356-18361
5. Mekhail T.M., and Markman M. Paclitaxel in cancer therapy. Expert Opin. Pharmacother. 3 6 (2002) 755-766
6. Jordan M.A., and Kamath K. How do microtubule-targeted drugs work? An overview. Curr. Cancer Drug Targets 7 8 (2007) 730-742
7. Scripture C.D., Figg W.D., and Sparreboom A. Peripheral neuropathy induced by Paclitaxel: recent insights and future perspectives. Curr. Neuropharmacol. 4 2 (2006) 165-172
8. Siau C., and Bennett G.J. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth. Analg. 102 5 (2006) 1485-1490
9. Liao P.C., et al. Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis. J. Cell Biochem. 104 4 (2008) 1509-1523
10. Wang M.S., et al. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127 Pt 3 (2004) 671-679
11. Boehmerle W., et al. Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation. Proc. Natl. Acad. Sci. U.S.A. 104 26 (2007) 11103-11108
12. Zozulya S., Ladant D., and Stryer L. Expression and characterization of calcium-myristoyl switch proteins. Methods Enzymol. 250 (1995) 383-393
13. Fisher J.R., et al. Purification of myristoylated and nonmyristoylated neuronal calcium sensor-1 using single-step hydrophobic interaction chromatography. Protein Exp. Purif. 20 1 (2000) 66-72
14. Celic A., et al. Domain mapping of the polycystin-2 C-terminal tail using de novo molecular modeling and biophysical analysis. J. Biol. Chem. 283 42 (2008) 28305-28312
15. Jeromin A., et al. N-terminal myristoylation regulates calcium-induced conformational changes in neuronal calcium sensor-1. J. Biol. Chem. 279 26 (2004) 27158-27167
16. Wang K.K. Calpain and caspase: can you tell the difference?. Trends Neurosci. 23 1 (2000) 20-26
17. Wang K.K., Villalobo A., and Roufogalis B.D. Calmodulin-binding proteins as calpain substrates. Biochem. J. 262 3 (1989) 693-706
18. O'Farrell P.A. Hydrophobic interaction chromatography. Methods Mol. Biol. 244 (2004) 133-138
19. Sussman J.L., et al. Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr. D: Biol. Crystallogr. 54 Pt 6 Pt 1 (1998) 1078-1084
20. Fear G., Komarnytsky S., and Raskin I. Protease inhibitors and their peptidomimetic derivatives as potential drugs. Pharmacol. Ther. 113 2 (2007) 354-368
21. Donkor I.O., and Korukonda R. Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position. Bioorg. Med. Chem. Lett. 18 17 (2008) 4806-4808